WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

APRE past revenue growth

How has APRE's revenue growth performed historically?
Company
410.91%
Industry
76.88%
Market
16.68%
APRE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
APRE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
APRE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

APRE earnings and revenue history

Current Revenue
$1.3M
Current Earnings
-$12.9M
Current Profit Margin
-1,013.4%

APRE Return on Equity

Current Company
-56.4%
Current Industry
23.1%
Current Market
34.1%
APRE's Return on Equity (-56.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when APRE announces earnings.

APRE Return on Assets

Current Company
-46.3%
Current Industry
3.6%
APRE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

APRE Return on Capital Employed

Current Company
-52.94%
Current Industry
21.5%
APRE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APRE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
APRE$1.28M-$14.21M-$12.93M+410.91%N/A
NERV$0.00-$33.61M-$33.65M-100.00%N/A
IPA$18.03M-$16.87M-$19.98M+16.94%N/A
GOVX$0.00-$26.83M-$26.92M-100.00%N/A
SPRB$9.57M-$44.45M-$43.11M+131.82%N/A
View Top Biotech Stocks

APRE earnings dates

Next earnings date
Nov 7, 2024

Aprea Therapeutics Earnings & Revenue FAQ

What were APRE's earnings last quarter?

On Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q2 2024 earnings per share (EPS) of -$0.58, up 33.33% year over year. Total Aprea Therapeutics earnings for the quarter were -$3.47 million. In the same quarter last year, Aprea Therapeutics's earnings per share (EPS) was -$0.87.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.

What was APRE's earnings growth in the past year?

As of Q3 2024, Aprea Therapeutics's earnings has grown year over year. Aprea Therapeutics's earnings in the past year totalled -$12.93 million.

What is APRE's earnings date?

Aprea Therapeutics's earnings date is Invalid Date. Add APRE to your watchlist to be reminded of APRE's next earnings announcement.

What was APRE's revenue last quarter?

On Invalid Date, Aprea Therapeutics (NASDAQ: APRE) reported Q2 2024 revenue of $561.57 thousand up 124.91% year over year. In the same quarter last year, Aprea Therapeutics's revenue was $249.69 thousand.

What was APRE's revenue growth in the past year?

As of Q3 2024, Aprea Therapeutics's revenue has grown 410.91% year over year. This is 334.03 percentage points higher than the US Biotechnology industry revenue growth rate of 76.88%. Aprea Therapeutics's revenue in the past year totalled $1.28 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.